close

Enter

Log in using OpenID

Cell Expansion Market

embed
Cell expansion is the large scale artificial production of daughter cells from a single cell, to support medical research.
Cell Expansion Market Trends, Growth And
Future Outlook By 2026
Cell expansion is the large scale artificial production of daughter cells from a single cell, to
support medical research. Rising preference for regenerative medicines offering faster results,
and emergence of cell-based therapies with high patient compatibility are expected to fuel the
cell expansion market during the forecast period (2017–2025). Regenerative medicine helps the
body to form new functional tissue to replace defective or lost ones providing treatment for
conditions with inadequate therapies. According to the U.S. Department of Health and Services,
in 2016, NIH invested around US$ 1.5 billion in stem cell research projects. Increasing
government and private sector expenditure on cell-based research therapies is expected to boost
growth of the market for cell expansion in the near future. The number of FDA approvals for
clinical trials of stem cell-based treatments is rapidly increasing. According to a report
published by Pharmaceutical Research and Manufacturers of America, in 2013, around 69 cell
therapies with clinical trials were under review with the FDA. The therapeutic classes
represented in these trials include skin diseases, cardiovascular diseases, transplantations, eye
conditions, cancer and associated conditions, musculoskeletal disorders, genetic disorders, and
digestive disorders.
Request PDF Brochure Of Research Report:
https://www.coherentmarketinsights.com/insight/request-pdf/1293
Increasing incidence of chronic medical conditions is expected to boost growth of the cell
expansion market over the forecast period
The increasing cases of chronic and rare medical conditions around the world is another key
factor driving demand for cell expansion. For instance, according to World Health Organization
(WHO), around 15 million people are projected to suffer from cancer by 2020. The rising
prevalence of cancer, is in turn, expected to boost growth of the cell expansion market. Cellbased therapy is also a promising approach for treating chronic kidney disease and is presently
the focus of preclinical studies. Recent advancements in regenerative medicine and tissue
engineering have created cell-based approaches for the treatment of renal failure. Such
treatments include biotechnological approach using implantation of bioengineered kidney
constructs, transplanting cells, and bio-artificial renal systems. However, lack of high-tech
instrumentation and skilled workforce coupled with the high cost of operations are expected to
hamper growth of the cell expansion market.
Report includes chapters which deeply display the following deliverable about industry :
• Cell Expansion Market Research Objective and Assumption
• Cell Expansion Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Cell Expansion Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Cell Expansion Market, By Regions
• Cell Expansion Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Cell Expansion Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Cell Expansion Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Cell Expansion Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
North America is expected to hold a dominant position in the cell expansion market due to
increasing demand for regenerative medicines and rising incidence of chronic diseases
Regional segmentation of the cell expansion market by Coherent Market Insights includes North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa. The cell expansion
market in North America is driven by the increasing demand for regenerative medicines that are
highly compatible with patients and offer rapid results. For instance, the FDA is increasingly
approving treatments involving cells derived from bone or blood marrow, due to its wellestablished efficacy and safety. Furthermore, increasing incidence of chronic diseases and rising
R&D investments for the development of cell-based products are other factors expected to
support growth of the cell expansion market. According to a study published in NIH report,
around 500,000 people benefit from a transplant each year using regenerative medicine in the
U.S. Increasing R&D expenditure by several companies for the development of new therapeutic
products and availability of untapped growth opportunities are expected to drive the cell
expansion market in Asia Pacific. Biotechnology merger and acquisition (M&A) activities have
also experienced a boost in the region. According to investment bank China Renaissance, in
2016, 37 pharmaceutical and biotech M&A deals worth US$ 6.8 billion were closed in China.
Major industry players use merger and acquisitions as their major growth strategy
Key players operating in the cell expansion market include Becton, Dickinson and Company,
Beckman Coulter, Inc., Corning, Inc., GE Healthcare, Lonza, Merck KGaA (Sigma-Aldrich Co.
LLC), Miltenyi Biotec, Thermo Fisher Scientific, Inc., Terumo BCT, Inc., and Stemcell
Technologies, Inc. In July 2016, GE Healthcare acquired Biosafe SA, a Swiss company that
manufactures instruments that recover stem cells and help in various other cell processing
procedures related to personalized medicine. This acquisition will help GE Healthcare to grow
the cells in the sample for appropriate dose sizes.
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/ongoing-insight/cell-expansion-market-1293
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
Author
Alex Huge
Alex Huge339   documents Email
Document
Category
Health and Medicine
Views
2
File Size
110 KB
Tags
Cell Expansion Market, market
1/--pages
Report inappropriate content